Avalon Investment & Advisory Novartis Ag Transaction History

Avalon Investment & Advisory

  • $3.56 Billion
  • Q1 2023

A detailed history of Avalon Investment & Advisory transactions in Novartis Ag stock. As of the latest transaction made, Avalon Investment & Advisory holds 42,250 shares of NVS stock, worth $4.19 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
42,250
Previous 43,544 2.97%
Holding current value
$4.19 Million
Previous $3.95 Million 1.59%
% of portfolio
0.11%
Previous 0.11%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $103,558 - $120,096
-1,294 Reduced 2.97%
42,250 $3.89 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $193,105 - $236,481
-2,556 Reduced 5.54%
43,544 $3.95 Million
Q3 2022

Nov 01, 2022
SELL
$74.61 - $87.26 $138,028 - $161,431
-1,850 Reduced 3.86%
46,100 $3.5 Million
Q2 2022

Aug 10, 2022
SELL
$80.52 - $93.75 $168,930 - $196,687
-2,098 Reduced 4.19%
47,950 $4.05 Million
Q1 2022

May 17, 2022
BUY
$80.11 - $90.62 $1.01 Million - $1.14 Million
12,548 Added 33.46%
50,048 $4.39 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $1.58 Million - $1.75 Million
-19,864 Reduced 34.63%
37,500 $3.28 Million
Q3 2021

Nov 08, 2021
SELL
$81.78 - $95.14 $1.34 Million - $1.56 Million
-16,345 Reduced 22.18%
57,364 $4.69 Million
Q2 2021

Jul 29, 2021
BUY
$85.24 - $94.15 $614,495 - $678,727
7,209 Added 10.84%
73,709 $6.73 Million
Q1 2021

May 13, 2021
SELL
$83.5 - $98.47 $560,368 - $660,832
-6,711 Reduced 9.17%
66,500 $5.68 Million
Q4 2020

Feb 08, 2021
SELL
$78.07 - $94.43 $65,969 - $79,793
-845 Reduced 1.14%
73,211 $6.91 Million
Q3 2020

Nov 04, 2020
SELL
$82.14 - $91.0 $873,312 - $967,512
-10,632 Reduced 12.55%
74,056 $6.44 Million
Q2 2020

Aug 07, 2020
SELL
$80.93 - $91.1 $1.55 Million - $1.74 Million
-19,093 Reduced 18.4%
84,688 $7.4 Million
Q1 2020

May 05, 2020
SELL
$70.67 - $99.01 $190,384 - $266,732
-2,694 Reduced 2.53%
103,781 $8.56 Million
Q4 2019

Feb 14, 2020
BUY
$84.35 - $95.37 $719,505 - $813,506
8,530 Added 8.71%
106,475 $10.1 Million
Q3 2019

Nov 14, 2019
BUY
$85.54 - $94.26 $334,375 - $368,462
3,909 Added 4.16%
97,945 $8.51 Million
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $2.2 Million - $2.71 Million
29,173 Added 44.98%
94,036 $8.59 Million
Q1 2019

Apr 24, 2019
BUY
$75.32 - $86.15 $1.52 Million - $1.73 Million
20,137 Added 45.02%
64,863 $6.24 Million
Q4 2018

Feb 14, 2019
BUY
$73.66 - $82.02 $206,910 - $230,394
2,809 Added 6.7%
44,726 $3.84 Million
Q3 2018

Nov 14, 2018
BUY
$66.94 - $77.43 $457,534 - $529,234
6,835 Added 19.48%
41,917 $3.61 Million
Q2 2018

Aug 14, 2018
SELL
$64.91 - $73.36 $60,885 - $68,811
-938 Reduced 2.6%
35,082 $2.65 Million
Q1 2018

Jun 26, 2018
SELL
$70.39 - $84.15 $179,424 - $214,498
-2,549 Reduced 6.61%
36,020 $2.91 Million
Q1 2018

Jun 22, 2018
BUY
$70.39 - $84.15 $179,424 - $214,498
2,549 Added 7.08%
38,569 $3.24 Million
Q1 2018

May 15, 2018
SELL
$70.39 - $84.15 $179,424 - $214,498
-2,549 Reduced 6.61%
36,020 $2.91 Million
Q4 2017

Jun 22, 2018
SELL
$72.33 - $77.64 $21,988 - $23,602
-304 Reduced 0.78%
38,569 $3.24 Million
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $258,001 - $276,941
3,567 Added 10.1%
38,873 $3.26 Million
Q3 2017

Nov 14, 2017
SELL
$74.14 - $77.27 $1.99 Million - $2.08 Million
-26,857 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
26,857
26,857 $2.24 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Avalon Investment & Advisory Portfolio

Follow Avalon Investment & Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Investment & Advisory with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email